Sustained release small molecule drug formulation
US11110093B2 · kind B2 · utility
0Cited by
140References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 15, 2019 |
| Grant date | Sep 7, 2021 |
| Priority date | — |
| Expiry date | Aug 24, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/18
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An injectable depot formulation includes a biocompatible polymer, an organic solvent combined with the biocompatible polymer to form a viscous gel, and a small molecule drug incorporated in the viscous gel such that the formulation exhibits an in vivo release profile having a Cmax to Cmin ratio of less than 200 and a lag time less than 0.2.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.